Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barin

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Journal of Virological Methods|February 1, 1995
A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1D Brand, F Mallet, C Truong, et al.
Journal of Clinical Microbiology|June 1, 1993
Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-IIJ Bonis, A Baillou, F Barin, et al.
Pathologie-Biologie|December 1, 1983
[Detection of IgM anti-hepatitis A antibodies by immunoenzyme technic. Interpretation of results and comparison of 2 tests (Havab-M EIA and Hepanostika anti-HAV IgM]F Barin, G Lesage, F Dubois, et al.
The Journal of Infectious Diseases|June 1, 1994
Lower serum hepatitis C virus RNA titers in patients with concurrent chronic hepatitis B virus infectionM François, P Roingeard, F Dubois, et al.
Epidemiology and Infection|August 1, 2019
Estimating prevalence from dried blood spots without using biological cut-offs: application of a novel approach to hepatitis C virus in drug users in France (ANRS-Coquelicot survey)L Léon, J Pillonel, M Jauffret-Roustide, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 5, 2009
[Quantitative estimate of the risk of blood donation contamination by infectious agents]J Pillonel, C Brouard, S Laperche, et al.
Lancet (London, England)|March 31, 1990
Symptomatic HIV-2 primary infectionJ M Besnier, F Barin, A Baillou, et al.
Developments in Biological Standardization|January 1, 1983
Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5)F Barin, A Goudeau, C Brechot, et al.
Journal of Virology|January 7, 1998
Extent of antigenic diversity in the V3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 group M and consequences for serotypingJ C Plantier, S Le Pogam, F Poisson, et al.
AIDS Research and Human Retroviruses|October 10, 1996
HIV type 1 diversity in northern Paris, FranceF Simon, I Loussert-Ajaka, F Damond, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Journal of Virological Methods|February 1, 1995
A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1D Brand, F Mallet, C Truong, et al.
Journal of Clinical Microbiology|June 1, 1993
Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-IIJ Bonis, A Baillou, F Barin, et al.
Pathologie-Biologie|December 1, 1983
[Detection of IgM anti-hepatitis A antibodies by immunoenzyme technic. Interpretation of results and comparison of 2 tests (Havab-M EIA and Hepanostika anti-HAV IgM]F Barin, G Lesage, F Dubois, et al.
The Journal of Infectious Diseases|June 1, 1994
Lower serum hepatitis C virus RNA titers in patients with concurrent chronic hepatitis B virus infectionM François, P Roingeard, F Dubois, et al.
Epidemiology and Infection|August 1, 2019
Estimating prevalence from dried blood spots without using biological cut-offs: application of a novel approach to hepatitis C virus in drug users in France (ANRS-Coquelicot survey)L Léon, J Pillonel, M Jauffret-Roustide, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 5, 2009
[Quantitative estimate of the risk of blood donation contamination by infectious agents]J Pillonel, C Brouard, S Laperche, et al.
Lancet (London, England)|March 31, 1990
Symptomatic HIV-2 primary infectionJ M Besnier, F Barin, A Baillou, et al.
Developments in Biological Standardization|January 1, 1983
Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5)F Barin, A Goudeau, C Brechot, et al.
Journal of Virology|January 7, 1998
Extent of antigenic diversity in the V3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 group M and consequences for serotypingJ C Plantier, S Le Pogam, F Poisson, et al.
AIDS Research and Human Retroviruses|October 10, 1996
HIV type 1 diversity in northern Paris, FranceF Simon, I Loussert-Ajaka, F Damond, et al.
Pageof 18